IE892931L - Use of ACE-inhibitors - Google Patents
Use of ACE-inhibitorsInfo
- Publication number
- IE892931L IE892931L IE892931A IE293189A IE892931L IE 892931 L IE892931 L IE 892931L IE 892931 A IE892931 A IE 892931A IE 293189 A IE293189 A IE 293189A IE 892931 L IE892931 L IE 892931L
- Authority
- IE
- Ireland
- Prior art keywords
- vessel
- prevention
- ace
- inhibitors
- neointima
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Prostheses (AREA)
Abstract
ACE inhibitors are able to suppress the formation of neointima and the reduction of the vessel volume owing to vessel wall thickening after a vessel injury. They are accordingly suitable for the treatment and prevention of neointima formation after vessel injury, in particular for the prevention of arterial restenosis after angioplasty or of vessel wall thickening after vascular surgery in arteries and veins.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH342188 | 1988-09-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
IE892931L true IE892931L (en) | 1990-03-14 |
Family
ID=4255625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE892931A IE892931L (en) | 1988-09-14 | 1989-09-13 | Use of ACE-inhibitors |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0363671B1 (en) |
JP (1) | JPH02121922A (en) |
KR (1) | KR900004337A (en) |
AT (1) | ATE100716T1 (en) |
AU (1) | AU625693B2 (en) |
DE (1) | DE58906814D1 (en) |
DK (1) | DK452089A (en) |
ES (1) | ES2061853T3 (en) |
HU (1) | HU206186B (en) |
IE (1) | IE892931L (en) |
IL (1) | IL91572A (en) |
PT (1) | PT91705B (en) |
ZA (1) | ZA896851B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3925759A1 (en) * | 1989-08-03 | 1991-02-07 | Thera Patent Verwaltungs Gmbh | USE OF ACE INHIBITORS FOR ATHEROSKLEROSEPROPHYLAXE |
DE3926606A1 (en) * | 1989-08-11 | 1991-02-14 | Hoechst Ag | METHOD FOR THE TREATMENT OF CARDIALS AND VASCULAR HYPERTROPHY AND HYPERPLASIA |
US5212165A (en) * | 1989-10-23 | 1993-05-18 | E. R. Squibb & Sons, Inc. | Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor |
US5061694A (en) * | 1989-10-23 | 1991-10-29 | E. R. Squibb & Sons, Inc. | Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor |
CA2042159A1 (en) * | 1990-05-31 | 1991-12-01 | Miguel A. Ondetti | Method for preventing onset of restenosis after angioplasty employing an ace inhibitor |
US5140012A (en) * | 1990-05-31 | 1992-08-18 | E. R. Squibb & Sons, Inc. | Method for preventing onset of restenosis after angioplasty employing pravastatin |
CA2052014A1 (en) * | 1990-10-19 | 1992-04-20 | Henry Y. Pan | Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor |
US5643911A (en) | 1994-05-19 | 1997-07-01 | Mitsubishi Chemical Corporation | Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia |
WO1996030035A1 (en) * | 1995-03-24 | 1996-10-03 | Molecumetics Ltd. | β-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS |
HUP9800757A3 (en) * | 1996-01-17 | 1998-08-28 | Taiho Pharmaceutical Co Ltd | Intimal thickening inhibitors containing oxyindole derivatives and pharmaceutical compositions containing them |
SI1216038T1 (en) * | 1999-08-30 | 2006-02-28 | Sanofi Aventis Deutschland | Ramipril for the prevention of cardiovascular events |
JP4904859B2 (en) * | 2006-03-13 | 2012-03-28 | 大日本印刷株式会社 | Printing unit and doctor blade polishing method |
MX2009000358A (en) * | 2006-07-10 | 2009-01-27 | Teva Pharma | Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105776A (en) | 1976-06-21 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
US4316906A (en) | 1978-08-11 | 1982-02-23 | E. R. Squibb & Sons, Inc. | Mercaptoacyl derivatives of substituted prolines |
AT377496B (en) | 1981-06-19 | 1985-03-25 | Voith Gmbh J M | DEVICE FOR WINDING A TRACK OF GOODS ON A NEWLY INSERTED WRAPPING SLEEVE IN A DOUBLE-CARRIER ROLLING MACHINE |
-
1989
- 1989-09-07 ZA ZA896851A patent/ZA896851B/en unknown
- 1989-09-08 IL IL9157289A patent/IL91572A/en not_active IP Right Cessation
- 1989-09-11 AU AU41240/89A patent/AU625693B2/en not_active Ceased
- 1989-09-11 HU HU894803A patent/HU206186B/en not_active IP Right Cessation
- 1989-09-11 KR KR1019890013099A patent/KR900004337A/en not_active Application Discontinuation
- 1989-09-13 PT PT91705A patent/PT91705B/en not_active IP Right Cessation
- 1989-09-13 IE IE892931A patent/IE892931L/en unknown
- 1989-09-13 JP JP1235895A patent/JPH02121922A/en active Pending
- 1989-09-13 DK DK452089A patent/DK452089A/en not_active Application Discontinuation
- 1989-09-14 EP EP89117050A patent/EP0363671B1/en not_active Expired - Lifetime
- 1989-09-14 ES ES89117050T patent/ES2061853T3/en not_active Expired - Lifetime
- 1989-09-14 DE DE89117050T patent/DE58906814D1/en not_active Expired - Fee Related
- 1989-09-14 AT AT89117050T patent/ATE100716T1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT91705B (en) | 1995-05-31 |
JPH02121922A (en) | 1990-05-09 |
HUT51148A (en) | 1990-04-28 |
DK452089A (en) | 1990-03-15 |
EP0363671A2 (en) | 1990-04-18 |
ES2061853T3 (en) | 1994-12-16 |
AU625693B2 (en) | 1992-07-16 |
KR900004337A (en) | 1990-04-12 |
ZA896851B (en) | 1990-06-27 |
EP0363671A3 (en) | 1991-12-11 |
HU206186B (en) | 1992-09-28 |
AU4124089A (en) | 1990-03-22 |
DK452089D0 (en) | 1989-09-13 |
IL91572A (en) | 1994-01-25 |
ATE100716T1 (en) | 1994-02-15 |
DE58906814D1 (en) | 1994-03-10 |
EP0363671B1 (en) | 1994-01-26 |
PT91705A (en) | 1990-03-30 |
IL91572A0 (en) | 1990-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE892931L (en) | Use of ACE-inhibitors | |
IE893123L (en) | Use of gamma-interferon for the treatment of vascular¹stenosis | |
HUP9802093A3 (en) | Use of nitrogen-monoxyde for producing medicament useful for treatment of vascular thrombosis and restenosis | |
DE69435137D1 (en) | PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ABNORMAL PROLIFERATION GLATTER MUSCLE CELLS | |
NO165986C (en) | PROTECTED ARTICLE. | |
EP1649853A3 (en) | Microtubule stabilizing agents for treating atherosclerosis or restenosis | |
NO992769D0 (en) | Procedure for the treatment and prevention of heart failure and ventricular dilation | |
EP0608853A3 (en) | Vascular dilatation instrument and catheter. | |
DE69121704D1 (en) | COMBINATION CATHETER FOR OBSERVATION AND DILATION OF BLOOD VESSELS | |
ATE253076T1 (en) | ANTITHROMBOTIC DRUGS | |
HUT64231A (en) | Process for the production of medical preparatives containing heparing and rapamycin for the preventing and treatment of blood-vessel diseases caused by hyper proliferation | |
AU5537994A (en) | Therapeutic treatment for inhibiting vascular restenosis | |
ITPN920087A1 (en) | MACHINE FOR THE TREATMENT AND STORAGE OF DISHES. | |
AU6178094A (en) | Polyurethane-coated intravascular prostheses (stents) for the treatment of blood vessel stenosis | |
ATE216888T1 (en) | DESFERRI-EXOCHELINE FOR THE TREATMENT OF ATHEROSCLERosis AND VASCULAR DAMAGE BY PREVENTING SMOOTH MUSCLE CELL PROLIFERATION | |
ATE164521T1 (en) | ANTI-GROWTH FACTOR ANTIBODIES IN THE TREATMENT OF VASCULAR STENOSIS | |
NO924637L (en) | PROCEDURE FOR PREVENTING REPEATING OF ARTERIES | |
EP0661981A1 (en) | Use of hyaluronic acid and forms to prevent arterial restenosis. | |
EP0407229A3 (en) | Laser catheter apparatus for use in arteries or other narrow paths within living organisms | |
UA37249C2 (en) | Method for inhibiting stenosis and/or restenosis (variants), method for inhibiting restenosis upon surgery of coronary artery (variants), method for decreasing risk of non-acute ischemic complication upon reconstructive vascular surgery | |
Elbert et al. | Endoluminal stent coatings consisting of adsorbing copolymers reduce neointimal hyperplasia in the pig | |
CS846287A1 (en) | Aid for vascular prostheses treatment of venous origin | |
FR2669826B1 (en) | CATHETER FOR DILATION OF THE ARTERIES. | |
IT228470Y1 (en) | CATHETER FOR THE DESTRUCTION OF THE ARTERIES | |
BG101472A (en) | Vascular transplant and method for its preparation |